BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1

被引:0
|
作者
Elizabeth A Williamson
Farnaz Dadmanesh
H Phillip Koeffler
机构
[1] Cedars-Sinai Medical Center,Department of Medicine
[2] UCLA School of Medicine,Department of Anatomic Pathology
[3] Cedars-Sinai Medical Center,undefined
[4] UCLA School of Medicine,undefined
来源
Oncogene | 2002年 / 21卷
关键词
BRCA1; p27; transcriptional regulation;
D O I
暂无
中图分类号
学科分类号
摘要
The p27Kip1 is a member of the universal cyclin-dependent kinase inhibitor family. Previously, immunochemical analysis of a series of breast cancer cell lines demonstrated a correlation between the expression of p27Kip1 and the breast cancer susceptibility gene BRCA1. BRCA1 has a number of activities including DNA repair, growth inhibition and as a transcription factor. Here we demonstrate that BRCA1 transactivates expression of p27Kip1. This transactivation is dependent on the presence of a functional C-terminal transactivation domain. Promoter-deletion analysis identified the presence of a putative BRCA1-responsive element located at position −615 to −511 of the p27Kip1 promoter. These results suggest that the transcriptional regulation of p27Kip1 by BRCA1 may be a mechanism for BRCA1- induced growth inhibition.
引用
收藏
页码:3199 / 3206
页数:7
相关论文
共 50 条
  • [1] BRCA1 transactivates the cyclin-dependent kinase inhibitor p27Kip1
    Williamson, EA
    Dadmanesh, F
    Koeffler, HP
    ONCOGENE, 2002, 21 (20) : 3199 - 3206
  • [2] Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27Kip1
    Hiromura, K
    Pippin, JW
    Fero, ML
    Roberts, JM
    Shankland, SJ
    JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (05): : 597 - 604
  • [3] Expression of cyclin-dependent kinase inhibitor p27kip1 in malignant lymphomas
    Oh, YH
    Park, CK
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2000, 15 (04) : 399 - 406
  • [4] Modulation of astrocyte proliferation by cyclin-dependent kinase inhibitor p27Kip1
    Koguchi, K
    Nakatsuji, Y
    Nakayama, K
    Sakoda, S
    GLIA, 2002, 37 (02) : 93 - 104
  • [5] The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury
    Vuddhidej Ophascharoensuk
    Matthew L. Fero
    Jeremy Hughes
    James M. Roberts
    Stuart J. Shankland
    Nature Medicine, 1998, 4 : 575 - 580
  • [6] Adenoviral expression of the cyclin-dependent kinase inhibitor p27kip1:: A strategy for cholangiocarcinoma
    Katayose, Y
    Suzuki, M
    Unno, M
    Takemura, S
    Fujiwara, K
    Yamamoto, K
    Yoshida, H
    Cowan, KH
    Seth, P
    Matsuno, S
    GASTROENTEROLOGY, 1999, 116 (04) : A434 - A434
  • [7] The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury
    Ophascharoensuk, V
    Fero, ML
    Hughes, J
    Roberts, JM
    Shankland, SJ
    NATURE MEDICINE, 1998, 4 (05) : 575 - 580
  • [8] Prognostic value of the cyclin-dependent kinase inhibitor p27Kip1 in gastric cancer
    Müller, W
    Grabsch, H
    Takeno, S
    Noguchi, T
    Hommel, G
    Gabbert, HE
    ANTICANCER RESEARCH, 2000, 20 (3A) : 1787 - 1792
  • [9] Minimal requirements for the nuclear localization of p27Kip1, a cyclin-dependent kinase inhibitor
    Zeng, Y
    Hirano, K
    Hirano, M
    Nishimura, J
    Kanaide, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 274 (01) : 37 - 42
  • [10] Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 in feline lymphoma
    Madewell, B
    Griffey, S
    Walls, J
    Gandour-Edwards, R
    VETERINARY PATHOLOGY, 2001, 38 (06) : 698 - 702